Literature DB >> 20951669

Expression of TLR-4 and -2 in peripheral mononuclear cells in renal transplant patients with TLR-4 gene polymorphism.

Eliana Nogueira1, Reinaldo Salomao, Milena Karina Colló Brunialti, Kikumi S Ozaki, Geórgia D M Marques, Marcos A Cenedeze, Niels Olsen Saraiva Câmara, Alvaro Pacheco-Silva.   

Abstract

INTRODUCTION: TLR-4 has also been identified as a receptor for endogenous alarmins, which are increased post transplantation. TLR-4 has also been associated with a polymorphism that could impact graft outcome.
OBJECTIVE: To assess the expression of TLR-4 in kidney transplant patients carrying or not a polymorphism.
METHODS: TLR-4 polymorphism (A299G/T399I) was studied in 200 renal transplant patients. Healthy volunteers were also enrolled as control group. The polymorphism analysis was performed using restriction enzymes technique (RFLP). Functionality of TLR-4 polymorphism was assessed in samples from controls by quantification of TNF-α after LPS stimulus. TLR-4 and -2 expressions were also analyzed by flow cytometry.
RESULTS: TLR-4 polymorphism was present in 8.5% of renal transplant patients. This polymorphism was associated with impairment in TNF-α secretion. In general, in renal transplant patients, TLR-4 expression in monocytes and in neutrophils was lower than in health volunteers. TLR-2 and TLR-4 expressions in healthy volunteers with A299G/T399I TLR-4 polymorphism was higher than in wild-type genotype healthy volunteers (p<0.01 and p<0.05, respectively), and also higher than A299G/T399I TLR-4 polymorphism renal transplant patients (p<0.05). TLR-2 expression on neutrophils in wild-type genotype renal transplant patients was higher compared to wild-type genotype healthy volunteers, and was also higher in relation to A299G/T399I kidney transplanted patients (p<0.01).
CONCLUSION: Stable renal transplant patients with TLR-4 polymorphism have a lower expression of TLR-4 and TLR-2 receptors in peripheral mononuclear cells, which ultimately indicate a less responsiveness for alarmins.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20951669     DOI: 10.1016/j.intimp.2010.09.005

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  4 in total

1.  Donor polymorphisms of toll-like receptor 4 associated with graft failure in liver transplant recipients.

Authors:  William S Oetting; Weihua Guan; David P Schladt; Robert E Leduc; Pamala A Jacobson; Arthur J Matas; Srinath Chinnakotla; Bernd Schröppel; Barbara T Murphy; Ajay K Israni
Journal:  Liver Transpl       Date:  2012-12       Impact factor: 5.799

Review 2.  Inflammation in Renal Diseases: New and Old Players.

Authors:  Vinicius Andrade-Oliveira; Orestes Foresto-Neto; Ingrid Kazue Mizuno Watanabe; Roberto Zatz; Niels Olsen Saraiva Câmara
Journal:  Front Pharmacol       Date:  2019-10-08       Impact factor: 5.810

3.  AIM2 as a putative target in acute kidney graft rejection.

Authors:  Nathália Franchon Marques Tejada; João Vitor Ziroldo Lopes; Luis Eduardo Duarte Gonçalves; Izabela Mamede Costa Andrade da Conceição; Glória Regina Franco; Bruno Ghirotto; Niels Olsen Saraiva Câmara
Journal:  Front Immunol       Date:  2022-09-30       Impact factor: 8.786

4.  Altered Expression of TLR2 and TLR4 on Peripheral CD14+ Blood Monocytes in Children with Urinary Tract Infection.

Authors:  Panagiota Karananou; Alexandra Fleva; Despoina Tramma; Anastasia Alataki; Aikaterini Pavlitou-Tsiontsi; Maria Emporiadou-Peticopoulou; Efimia Papadopoulou-Alataki
Journal:  Biomed Res Int       Date:  2016-05-05       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.